Skip to content
Screener

Celcuity CELC Price / book

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
31.6×-6.7×
Gilead Sciences logo
Gilead SciencesGILD
13.3×+6.5×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
4.6×+3.7×
Immunome logo
ImmunomeIMNM
4.2×+2.3×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
3.4×+1.6×
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
2.7×-0.1×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on the most recent quarter.

The source filing: Celcuity’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 5:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023180

FAQ

What is Celcuity's price / book?
Celcuity (CELC) reported price / book of 103.1× in Q1 2026.
How has Celcuity's price / book changed year-over-year?
Celcuity's price / book increased by 2279.9% year-over-year, from 4.3× to 103.1×.
What is the long-term trend for Celcuity's price / book?
Over 5 years (2020 to 2025), Celcuity's price / book has grown at a 31.5% compound annual growth rate (CAGR), from 11.7× to 45.9×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Celcuity's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude